Lake Forest, CA medtech leader David Ferrera calls for stronger collaboration between physicians and engineers to improve neurovascular outcomes.
LAKE FOREST, CA / ACCESS Newswire / April 21, 2026 / David Ferrera, CEO of RC Medical and CEO and Chairman of Sonorous Neuro, is calling for increased awareness and support for physician-led innovation in neurovascular care. Drawing on nearly three decades of experience in the medical device industry, Ferrera is advocating for a more structured, collaborative approach to solving real clinical challenges in stroke treatment.
Stroke remains one of the leading causes of death and disability worldwide. According to the CDC, nearly 795,000 people in the United States suffer a stroke each year, and someone experiences a stroke every 40 seconds. In ischemic stroke cases, an estimated 1.9 million neurons are lost every minute without treatment, making speed and precision critical.
“Minutes matter,” Ferrera said. “I’ve been in procedure rooms where a device worked technically, but added unnecessary steps. Every extra minute has consequences for the patient.”
Ferrera’s work focuses on bridging the gap between clinical insight and product development. Through RC Medical, he partners directly with physicians who identify recurring issues in real procedures. Together, they develop targeted solutions designed to improve workflow, reduce risk, and enhance patient outcomes.
“Doctors see where things break down,” he explained. “They know what slows a procedure or adds complexity. When you start with that insight, you build better tools.”
Ferrera emphasized that many medical innovations fail not because of a lack of ideas, but because of a lack of structured execution.
“Innovation is not the hard part,” he said. “Translation is. You have to take that idea and carry it through testing, regulation, and real-world use. If it doesn’t work in a live case, it doesn’t matter.”
His perspective comes from firsthand experience building and scaling multiple medical device companies, including Micrus Endovascular, MindFrame, and Blockade Medical, all of which were later acquired by major industry players. Today, he continues that work through a venture studio model that supports early validation and milestone-driven development.
“Physicians don’t need to become full-time entrepreneurs,” Ferrera added. “But they should document what they see. If a problem happens every week, it’s worth solving.”
Despite major advances in stroke care, including the adoption of mechanical thrombectomy, gaps remain in access, efficiency, and consistency across hospitals. Ferrera believes that closer collaboration between clinicians, engineers, and investors can help close those gaps.
“We’ve made progress,” he said. “But I’ve also seen cases where workflow issues still slow things down. That’s where better design makes a difference.”
He also highlighted the importance of awareness beyond the medical community. Early recognition of stroke symptoms can significantly improve outcomes. The American Stroke Association promotes the FAST acronym – Face drooping, Arm weakness, Speech difficulty, Time to call emergency services – as a simple way for individuals to act quickly.
“Technology helps, but only if patients arrive in time,” Ferrera noted. “Public awareness is just as important as device innovation.”
Call to Action
Ferrera encourages physicians to document recurring procedural challenges and engage with experienced development partners. Engineers and product teams are urged to spend time observing real procedures to better understand workflow demands. Investors are encouraged to support disciplined, milestone-based development rather than speculative trends. Individuals can learn stroke warning signs, support cardiovascular research organizations, and advocate for faster emergency response in their communities.
Progress in neurovascular care depends on shared responsibility and practical action at every level.
To read the full interview, visit the website here.
About David Ferrera
David Ferrera is a Lake Forest, California-based engineer, entrepreneur, and inventor with nearly 30 years of experience in the medical device industry. He is CEO of RC Medical and CEO and Chairman of Sonorous Neuro. Over his career, he has co-founded and led multiple companies focused on neurovascular and interventional technologies, guiding them from concept through commercialization and acquisition. He holds more than 80 U.S. and international patents and is the author of Innovation in Translation. Ferrera has also served as Chair of the American Heart Association’s Orange County Heart & Stroke Ball.
Contact:
Info@davidferreraentrepreneur.com
SOURCE: David Ferrera
View the original press release on ACCESS Newswire
